A 67 year old man presented with worsening cough and shortness of breath. He has a history of metastatic colon cancer first diagnosed in 2010. He was treated with radiation and chemotherapy (FOLFOX) but unfortunately developed new pulmonary nodules in October, 2013 which were metastatic colon cancer on biopsy. In February 2014 he developed a right parietal brain mass which was resected. Thoracic CT scan at that time showed progression of the pulmonary nodules. He has also noted a 30 pound weight loss over the past 6 months and an enlarging right supraclavicular lymph node.
History of Present Illness
A 67 year old man presented with worsening cough and shortness of breath. He has a history of metastatic colon cancer first diagnosed in 2010. He was treated with radiation and chemotherapy (FOLFOX) but unfortunately developed new pulmonary nodules in October, 2013 which were metastatic colon cancer on biopsy. In February 2014 he developed a right parietal brain mass which was resected. Thoracic CT scan at that time showed progression of the pulmonary nodules. He has also noted a 30 pound weight loss over the past 6 months and an enlarging right supraclavicular lymph node.
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In addition to the colon cancer, he has previous diagnoses of type 2 diabetes mellitus, hypertension, allergic rhinitis, and vitamin D deficiency. He is married and a recently retired railroad engineer. He has no history of tobacco use. There is a positive family history of lung cancer but no colon cancer.
Physical Examination
Vital Signs: Temperature 36.8, pulse 98, respirations 18, blood pressure 144/70, SpO2 91% on 3 L via nasal cannula. Pertinent findings include:
A large firm and fixed right supraclavicular lymph node that is nonpainful on palpation.
Diminished breath sounds across all right posterior lung fields with dullness to percussion. Palpable liver edge is palpable approximately 2cm below the right costal margin.
Laboratory Analysis
Admission laboratory values include a hemoglobin of 11.1 g/dL but with a normal white blood cell count and platelet count. Electrolytes, blood urea nitrogen, creatinine, and liver enzymes were all within normal limits. Serum chemistries are within normal limits. 
Correct! 2. Right lung atelectasis
The chest x-ray shows evidence of volume loss on the right (Figure 2 ). Atelectasis is associated with volume loss while pleural effusion, pneumonia and pulmonary edema are not.
What is the next step in evaluating the patient? Our patient had significant improvement in his dyspnea from debulking of the soft, necrotic tumor in right mainstem bronchus with argon plasma coagulation to control bleeding and extensive suctioning of purulent airway secretions. His chest x-ray also showed significant improvement ( Figure 5 ). The prevalence of endobronchial metastases is about 2% based on autopsy studies (2) . However, the prevalence increases to 18-42% in patients with pulmonary metastases. Endobronchial metastases are most frequently observed in cancers from the breast, kidney, colorectal, uterine cervix, sarcoma and skin cancers (2) . In a review of the literature, the mean time from diagnosis of the primary tumor was 50 months (range 0-300 months) and mean survival time from the diagnosis of endobronchial metastasis was 15.2 months (range 0-150 months) (2) . Endobronchial metastases from colon cancer reflects these trends. In a series of 42 patients, average survival from primary diagnosis: 70 months (23-245) but median survival after endobronchial metastases were detected was only 14 months (3-40) (3).
